Forget what you know about the number 666. If series of sixes, like 666, are popping up everywhere, you have no reason to fear: This sequence is associated with love and connection, according to ...

Editor's note: Last updated following the Dec. 10, 2025 drawing. Let's face it. You face some pretty steep odds to win the Powerball jackpot, like a 1 in 292.2 million chance. So is there any way to ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Posts circulating on social media claim Mamdani is expected to introduce new rules when he becomes New York Mayor in 2026 that will require all public elementary schools in the state to learn Arabic ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

Employers added only 22,000 jobs in August, and the unemployment rate rose slightly to 4.3 percent. Revised data also showed that employment fell by 13,000 jobs in June, the first net loss since ...

This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...